[Remote] Associate Director Government Affairs & Market Access at Illumina

Austria

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, GenomicsIndustries

Requirements

University degree in Public Policy, Health Economics, Life Sciences, or a related field
Extensive experience in government affairs, market access, or healthcare policy within the life sciences, diagnostics, or pharmaceutical sector
In-depth knowledge of healthcare systems and reimbursement frameworks in Central Europe (particularly Poland, Czech Republic, Baltics, or similar markets)
Proven ability to influence policy and payer decision-making through strategic engagement and evidence-based advocacy
Strong communication and interpersonal skills, with experience working cross-functionally and internationally
Fluent in English; proficiency in Polish or another Central European language highly desirable
Based in Austria with approximately 50% travel across European countries

Responsibilities

Develop and execute integrated strategies that align government affairs and market access objectives to support Illumina’s mission across Central Europe
Build and maintain trusted relationships with key stakeholders including government ministries, health authorities, HTA bodies, payers, and regulatory institutions
Shape national policy and reimbursement environments to support sustainable patient access to innovative genomic testing
Lead the development of country-specific access strategies, incorporating policy, pricing, and evidence generation elements
Represent Illumina in relevant policy forums, working groups, and trade associations to position the company as a partner in advancing precision medicine
Monitor and analyze relevant legislative, regulatory, and reimbursement developments, providing strategic insights and guidance to internal teams
Engage with HTA agencies and payers to articulate the clinical and economic value of genomics, adapting global value dossiers to local contexts
Identify evidence gaps and coordinate with cross-functional teams (e.g., Medical Affairs, Patient Advocacy, Comms, and Regulatory) to support local evidence generation and publications

Skills

Healthcare Policy

Payer Engagement

Government Relations

Reimbursement Strategies

Stakeholder Management

Policy Alignment

Market Access

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free